5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.52▼ | 1.52▼ | 1.52▼ | 1.50▲ | 1.45▲ |
MA10 | 1.48▲ | 1.48▲ | 1.48▲ | 1.45▲ | 1.53▲ |
MA20 | 1.48▲ | 1.48▲ | 1.48▲ | 1.45▲ | 1.56▼ |
MA50 | 1.53▼ | 1.55▼ | 1.56▼ | 1.53▲ | 1.83▼ |
MA100 | 1.58▼ | 1.55▼ | 1.56▼ | 1.57▼ | 2.87▼ |
MA200 | 1.60▼ | 1.64▼ | 1.66▼ | 1.75▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.013▲ | 0.014▲ | 0.014▲ | 0.020▲ | 0.024▲ |
RSI | 55.024▲ | 53.446▲ | 52.280▲ | 59.792▲ | 43.648▼ |
STOCH | 92.148▲ | 92.148▲ | 92.148▲ | 78.070 | 23.110 |
WILL %R | -17.241▲ | -17.241▲ | -17.241▲ | -6.383▲ | -53.191 |
CCI | 79.772 | 79.772 | 81.014 | 152.057▲ | -20.480 |
MA | $GIPR Price Crossed Above MA(50) | Set Alert |
Monday, June 30, 2025 05:32 PM
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon (GCG) receptors ...
|
Monday, June 30, 2025 02:30 PM
NEWARK, CALIFORNIA / ACCESS Newswire / June 30, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) today announced the selection of PN-477, a potential best-in-class ...
|
Monday, June 30, 2025 01:30 PM
TAMPA, FL / ACCESS Newswire / June 30, 2025 / Generation Income Properties, Inc. (NASDAQ:GIPR) ("GIPR" or the "Company"), a net lease real estate investment trust focused on strategically located ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 1.48 | 1.565 | 1.48 | 1.55 | 22,202 |
02/07/25 | 1.49 | 1.5332 | 1.46 | 1.50 | 22,525 |
01/07/25 | 1.48 | 1.55 | 1.48 | 1.50 | 27,228 |
30/06/25 | 1.47 | 1.50 | 1.42 | 1.46 | 24,494 |
27/06/25 | 1.41 | 1.47 | 1.41 | 1.47 | 17,352 |
26/06/25 | 1.44 | 1.45 | 1.3797 | 1.42 | 8,157 |
25/06/25 | 1.38 | 1.43 | 1.38 | 1.42 | 8,072 |
24/06/25 | 1.37 | 1.4089 | 1.37 | 1.40 | 4,355 |
23/06/25 | 1.39 | 1.40 | 1.363 | 1.39 | 14,028 |
20/06/25 | 1.36 | 1.39 | 1.332 | 1.35 | 19,519 |
|
|
||||
|
|
||||
|
|